7/28/2017
`
`ca20948 - PubMed - NCBI
`
`PubMed
`
`ca20948
`
`Format: Summary
`
`Sort by: Publication Date
`
`Per page: 100
`
`Search results
`Items: 37
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`Filters activated: Publication date to 2005/10/31. Clear all to show 54 items.
`111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of
`peptide receptor radionuclide therapy.
`Capello A, Krenning E, Bernard B, Reubi JC, Breeman W, de Jong M.
`Eur J Nucl Med Mol Imaging. 2005 Nov;32(11):1288-95. Epub 2005 Jul 15.
`PMID: 16021448
`
`Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.
`de Jong M, Breeman WA, Valkema R, Bernard BF, Krenning EP.
`J Nucl Med. 2005 Jan;46 Suppl 1:13S-7S.
`Free Article
`PMID: 15653647
`
`Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and
`related tumors in rodents.
`Sun L, Fuselier JA, Coy DH.
`Drug Deliv. 2004 Jul-Aug;11(4):231-8.
`PMID: 15371104
`
`Low-dose-rate irradiation by 131I versus high-dose-rate external-beam irradiation in the rat pancreatic tumor
`cell line CA20948.
`Verwijnen S, Capello A, Bernard B, van den Aardweg G, Konijnenberg M, Breeman W, Krenning E, de Jong M.
`Cancer Biother Radiopharm. 2004 Jun;19(3):285-92.
`PMID: 15285875
`
`Radionuclide tumour therapy with ultrasound contrast microbubbles.
`van Wamel A, Bouakaz A, Bernard B, ten Cate F, de Jong N.
`Ultrasonics. 2004 Apr;42(1-9):903-6.
`PMID: 15047404
`
`Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with
`prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells.
`Boulay A, Zumstein-Mecker S, Stephan C, Beuvink I, Zilbermann F, Haller R, Tobler S, Heusser C, O'Reilly T, Stolz
`B, Marti A, Thomas G, Lane HA.
`Cancer Res. 2004 Jan 1;64(1):252-61.
`Free Article
`PMID: 14729632
`
`Pharmacological properties of hydrophilic and lipophilic derivatives of octreotate.
`Wang Q, Graham K, Schauer T, Fietz T, Mohammed A, Liu X, Hoffend J, Haberkorn U, Eisenhut M, Mier W.
`Nucl Med Biol. 2004 Jan;31(1):21-30.
`PMID: 14741567
`
`https://www.ncbi.nlm.nih.gov/pubmed
`
`1/5
`
`Ex. 1075-0001
`
`

`

`8.
`
`ca20948 - PubMed - NCBI
`7/28/2017
`Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy
`results in vitro.
`Capello A, Krenning EP, Breeman WA, Bernard BF, Konijnenberg MW, de Jong M.
`Cancer Biother Radiopharm. 2003 Oct;18(5):761-8.
`PMID: 14629824
`
`Peptide receptor radionuclide therapy in vitro using [111In-DTPA0]octreotide.
`Capello A, Krenning EP, Breeman WA, Bernard BF, de Jong M.
`J Nucl Med. 2003 Jan;44(1):98-104.
`Free Article
`PMID: 12515882
`
`Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy
`and radionuclide therapy.
`Breeman WA, de Jong M, Erion JL, Bugaj JE, Srinivasan A, Bernard BF, Kwekkeboom DJ, Visser TJ, Krenning EP.
`J Nucl Med. 2002 Dec;43(12):1650-6.
`Free Article
`PMID: 12468515
`
`Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model.
`Lewis JS, Wang M, Laforest R, Wang F, Erion JL, Bugaj JE, Srinivasan A, Anderson CJ.
`Int J Cancer. 2001 Dec 15;94(6):873-7.
`Free Article
`PMID: 11745491
`
`Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model
`is dependent on tumor size.
`de Jong M, Breeman WA, Bernard BF, Bakker WH, Visser TJ, Kooij PP, van Gameren A, Krenning EP.
`J Nucl Med. 2001 Dec;42(12):1841-6.
`Free Article
`PMID: 11752083
`
`[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.
`de Jong M, Breeman WA, Bernard BF, Bakker WH, Schaar M, van Gameren A, Bugaj JE, Erion J, Schmidt M,
`Srinivasan A, Krenning EP.
`Int J Cancer. 2001 Jun 1;92(5):628-33.
`Free Article
`PMID: 11340564
`
`Radiotherapeutic efficacy of (153)Sm-CMDTPA-Tyr(3)-octreotate in tumor-bearing rats.
`Bugaj JE, Erion JL, Johnson MA, Schmidt MA, Srinivasan A.
`Nucl Med Biol. 2001 Apr;28(3):327-34.
`PMID: 11323245
`
`Comparative dosimetry of copper-64 and yttrium-90-labeled somatostatin analogs in a tumor-bearing rat model.
`Lewis JS, Laforest R, Lewis MR, Anderson CJ.
`Cancer Biother Radiopharm. 2000 Dec;15(6):593-604.
`PMID: 11190491
`
`Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted
`scintigraphy and radionuclide therapy.
`Bernard BF, Krenning E, Breeman WA, Visser TJ, Bakker WH, Srinivasan A, de Jong M.
`Nucl Med Commun. 2000 Nov;21(11):1079-85.
`PMID: 11192715
`
`Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
`
`9.
`
`10.
`
`11.
`
`12.
`
`13.
`
`14.
`
`15.
`
`16.
`
`17.
`
`https://www.ncbi.nlm.nih.gov/pubmed
`
`2/5
`
`Ex. 1075-0002
`
`

`

`ca20948 - PubMed - NCBI
`7/28/2017
`van Hagen PM, Breeman WA, Bernard HF, Schaar M, Mooij CM, Srinivasan A, Schmidt MA, Krenning EP, de Jong
`M.
`Int J Cancer. 2000 Aug 20;90(4):186-98.
`Free Article
`PMID: 10993959
`
`18.
`
`19.
`
`20.
`
`21.
`
`22.
`
`23.
`
`24.
`
`25.
`
`Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging.
`Achilefu S, Dorshow RB, Bugaj JE, Rajagopalan R.
`Invest Radiol. 2000 Aug;35(8):479-85.
`PMID: 10946975
`
`Radioiodination and astatination of octreotide by conjugation labeling.
`Vaidyanathan G, Affleck D, Welsh P, Srinivasan A, Schmidt M, Zalutsky MR.
`Nucl Med Biol. 2000 May;27(4):329-37.
`PMID: 10938466
`
`Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B
`receptor-targeted scintigraphy and radionuclide therapy.
`de Jong M, Bakker WH, Bernard BF, Valkema R, Kwekkeboom DJ, Reubi JC, Srinivasan A, Schmidt M, Krenning
`EP.
`J Nucl Med. 1999 Dec;40(12):2081-7.
`Free Article
`PMID: 10616889
`
`Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
`De Jong M, Breeman WA, Bernard HF, Kooij PP, Slooter GD, Van Eijck CH, Kwekkeboom DJ, Valkema R, Mäcke
`HR, Krenning EP.
`Q J Nucl Med. 1999 Dec;43(4):356-66.
`PMID: 10731786
`
`Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor
`scintigraphy.
`Breeman WA, De Jong M, Bernard BF, Kwekkeboom DJ, Srinivasan A, van der Pluijm ME, Hofland LJ, Visser TJ,
`Krenning EP.
`Int J Cancer. 1999 Nov 26;83(5):657-63.
`Free Article
`PMID: 10521803
`
`Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing
`rat model.
`Lewis JS, Lewis MR, Cutler PD, Srinivasan A, Schmidt MA, Schwarz SW, Morris MM, Miller JP, Anderson CJ.
`Clin Cancer Res. 1999 Nov;5(11):3608-16.
`Free Article
`PMID: 10589778
`
`New somatostatin analogues for radiotherapy of somatostatin receptor expressing tumours.
`Stolz B, Smith-Jones P, Albert R, Weckbecker G, Bruns C.
`Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S224-6. Review.
`PMID: 10604136
`
`Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the
`peptide amount.
`de Jong M, Breeman WA, Bernard BF, van Gameren A, de Bruin E, Bakker WH, van der Pluijm ME, Visser TJ,
`Mäcke HR, Krenning EP.
`Eur J Nucl Med. 1999 Jul;26(7):693-8.
`PMID: 10398816
`
`https://www.ncbi.nlm.nih.gov/pubmed
`
`3/5
`
`Ex. 1075-0003
`
`

`

`26.
`
`ca20948 - PubMed - NCBI
`7/28/2017
`Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
`Breeman WA, Hofland LJ, de Jong M, Bernard BF, Srinivasan A, Kwekkeboom DJ, Visser TJ, Krenning EP.
`Int J Cancer. 1999 May 17;81(4):658-65.
`Free Article
`PMID: 10225459
`
`27.
`
`28.
`
`29.
`
`30.
`
`31.
`
`32.
`
`33.
`
`Comparison of four 64Cu-labeled somatostatin analogues in vitro and in a tumor-bearing rat model: evaluation
`of new derivatives for positron emission tomography imaging and targeted radiotherapy.
`Lewis JS, Lewis MR, Srinivasan A, Schmidt MA, Wang J, Anderson CJ.
`J Med Chem. 1999 Apr 22;42(8):1341-7.
`PMID: 10212119
`
`In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target
`tissue uptake.
`Lewis JS, Srinivasan A, Schmidt MA, Anderson CJ.
`Nucl Med Biol. 1999 Apr;26(3):267-73.
`PMID: 10363797
`
`Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats.
`Anderson CJ, Jones LA, Bass LA, Sherman EL, McCarthy DW, Cutler PD, Lanahan MV, Cristel ME, Lewis JS,
`Schwarz SW.
`J Nucl Med. 1998 Nov;39(11):1944-51.
`Free Article
`PMID: 9829587
`
`Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin
`receptor-targeted scintigraphy and radionuclide therapy.
`De Jong M, Bernard BF, De Bruin E, Van Gameren A, Bakker WH, Visser TJ, Mäcke HR, Krenning EP.
`Nucl Med Commun. 1998 Mar;19(3):283-8.
`PMID: 9625504
`
`Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers
`for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
`De Jong M, Bakker WH, Breeman WA, Bernard BF, Hofland LJ, Visser TJ, Srinivasan A, Schmidt M, Béhé M,
`Mäcke HR, Krenning EP.
`Int J Cancer. 1998 Jan 30;75(3):406-11.
`Free Article
`PMID: 9455802
`
`Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides.
`Vallabhajosula S, Moyer BR, Lister-James J, McBride BJ, Lipszyc H, Lee H, Bastidas D, Dean RT.
`J Nucl Med. 1996 Jun;37(6):1016-22.
`Free Article
`PMID: 8683294
`
`In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-
`Arg1]substance P.
`Breeman WA, VanHagen MP, Visser-Wisselaar HA, van der Pluijm ME, Koper JW, Setyono-Han B, Bakker WH,
`Kwekkeboom DJ, Hazenberg MP, Lamberts SW, Visser TJ, Krenning EP.
`J Nucl Med. 1996 Jan;37(1):108-17.
`Free Article
`PMID: 8543978
`
`34.
`
`A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity,
`receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
`Breeman WA, Hofland LJ, van der Pluijm M, van Koetsveld PM, de Jong M, Setyono-Han B, Bakker WH,
`Kwekkeboom DJ, Visser TJ, Lamberts SW.
`
`https://www.ncbi.nlm.nih.gov/pubmed
`
`4/5
`
`Ex. 1075-0004
`
`

`

`7/28/2017
`Eur J Nucl Med. 1994 Apr;21(4):328-35.
`PMID: 7911760
`
`ca20948 - PubMed - NCBI
`
`35.
`
`36.
`
`37.
`
`Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and
`comparison with [123I-Tyr3]octreotide.
`Breeman WA, Hofland LJ, Bakker WH, van der Pluijm M, van Koetsveld PM, de Jong M, Setyono-Han B,
`Kwekkeboom DJ, Visser TJ, Lamberts SW, et al.
`Eur J Nucl Med. 1993 Nov;20(11):1089-94.
`PMID: 7904561
`
`Promotion by unsaturated fat of azaserine-induced pancreatic carcinogenesis in the rat.
`Roebuck BD, Yager JD Jr, Longnecker DS, Wilpone SA.
`Cancer Res. 1981 Oct;41(10):3961-6.
`Free Article
`PMID: 7285004
`
`Dietary modulation of azaserine-induced pancreatic carcinogenesis in the rat.
`Roebuck BD, Yager JD Jr, Longnecker DS.
`Cancer Res. 1981 Mar;41(3):888-93.
`Free Article
`PMID: 7459874
`
`Back to top
`
`https://www.ncbi.nlm.nih.gov/pubmed
`
`5/5
`
`Ex. 1075-0005
`
`